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Background/purpose Infantile haemangiomas are the
most common tumours of infancy, with an incidence of up
to 12%. The craniofacial area is affected in 60% of cases,
which represents a therapeutic challenge. The purpose
of this study was to evaluate the indications, results and
complications of early surgical management of craniofacial
haemangiomas.
Patients and methods Twenty-eight patients with
craniofacial haemangiomas (18 females and 10 males)
were subjected to surgical treatment between 2006 and
2010. They were presented within the first 2 years of life.
For each patient, the age, sex, site, indication of surgery
and postoperative complications were recorded.
Results All patients in the study had a single lesion.
Surgery consisted of complete, one-stage excision with
primary closure (19 patients) or closure with local flaps
(nine patients). Postoperative complications (25%)
included partial disruption (two patients), partial recurrence
(two patients) and one case each of haematoma, partial
skin necrosis and infection.
Conclusion Surgical treatment is the prime goal in
cases of haemangioma obstructing vital functions and
complicated haemangioma. Surgery offers a short-term
period of treatment with good results. Ann Pediatr Surg
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Introduction
Infantile haemangiomas are the most common tumours of
infancy, with an incidence of up to 12% by the end of the
first year [1]. It is more frequent in females than in males,
with a ratio of 3 : 1 [2]. It is usually a single lesion in 80%
of the cases [3]. Haemangiomas are proliferating vascular
neoplasms that have a proliferating phase, a stable phase
and then resolve spontaneously. However, 20–40% of
affected children are left with residual skin changes
ranging from telangiectasia, hyperpigmentation, hypo-
pigmentation or atrophic skin to fibrofatty residue or
permanent deformation of the ears, eye lids, nose or
lips [4–6]. The approach of wait and see is based on the
natural course of these lesions [4]. However, many
reports advocate early treatment [7–9].
The treatment of patients with extended vascular anom-
alies localized in the craniofacial area – present in 60% of
cases – represents a clinical challenge that is best dealt
with a multidisciplinary diagnostic and therapeutic
concept [10].
Well-established treatments for haemangiomas include
intralesional or systemic corticosteroids, IFNa, bleomycin
A5, laser therapy, cryotherapy, systemic propranolol and
surgical excision [11–16].
The classic indications for surgical resection of haemangioma
include obstruction of the visual axis, large haemangioma
with thrombocytopenia, obstruction of luminal structures,
uncontrollable ulceration, haemorrhage, infection, cardio-
pulmonary decompensation and small lesions that can be
excised without a cosmetic or a functional risk [17]. The aim
of this study was to evaluate the indications and outcome of
early surgical treatment of craniofacial haemangioma.
Patients and methods
In this study, information from the case notes of 28
patients with craniofacial haemangiomas subjected to
surgical treatment between January 2006 and September
2010 was collected.
The patients (18 females and 10 males) presented within
the first 2 years of life (mean age 15.6 months).
Early curative surgery was applied for nasal tip
haemangioma that caused cartilage distortion, labial
haemangioma that affected eating, haemangioma that
obstructed the visual field, haemangioma causing hyper-
dynamic circulation, complicated haemangioma (ulcera-
tion, infection, haemorrhage) and haemangioma posing a
psychosocial burden for the parents.
Excision of haemangioma was followed by primary closure
of the wound or closure with local flaps.
Patients with extensive haemagiomas involving a large
area of the craniofacial region were excluded from the
study (Figs 1 and 2).
Results
Twenty-eight patients under 2 years of age were
subjected to a surgical treatment of craniofacial haeman-
giomas (mean age 15.6 months) (Table 1).
Before surgical treatment, five patients were treated by
an intralesional corticosteroid injection one to three times
and another group of patients (three patients) were
treated by an intralesional injection of sclerosant (the two
groups were injected elsewhere). Both groups did not
show involution of the lesions. Moreover, one patient of
the sclerosant group showed deep ulceration (Fig. 8a and
b); a local steroid injection was administered in five
Original article 133
1687-4137 c 2011 Annals of Pediatric Surgery DOI: 10.1097/01.XPS.0000405091.05305.65
Copyright © Annals of Pediatric Surgery. Unauthorized reproduction of this article is prohibited.
patients, which caused skin thinning with underlying fat
necrosis in three patients. Oral prednisolone at a dose of
2–3 mg/kg/day was administered in six patients (4–6
weeks) to speed up involution of the lesions before
surgical resection.
Early curative surgery was performed for (Table 2) eight
patients with lip haemangioma (six upper lip, two lower
lip) (Figs 3a, b and 4a, b). Two patients underwent
surgical excision of nasal tip haemangioma. Among
patients with visual obstruction, surgery was performed
for two patients (Figs 5a, b and 6a, b). One patient with a
large occipital haemangioma underwent excision with
primary skin closure (Fig. 7a and b). Early surgery was
performed in five patients with cheek haemangiomas
(Figs 8a, b and 9a, b), two patients with external ear
haemangioma, four patients with frontal haemangioma,
two patients with retroauricular haemangioma, one
patient with haemangioma of the temporal region and
one patient with haemangioma at the angle of the
mandible.
The indications for surgery are summarized in Table 3.
Patients who were presented with inflammation, infec-
tion or ulceration were prepared with systemic and local
antibiotics; however, haemodynamic stability was not
affected in patients who were presented with repeated
haemorrhage.
As regards postoperative complications (25%) (Table 4),
two patients with upper lip haemangioma showed partial
disruption of the mucosal aspect on the eighth and 10th
postoperative days (treated conservatively); partial ne-
crosis of the skin flap had occurred in one patients with
cheek haemangioma and healed with secondary intention.
Infection had occurred in a patient with large scalp
haemangioma (treated with systemic and local antibio-
tics), whereas one patient with retroauricular haemangio-
ma showed haematoma formation (evacuated surgically).
Partial recurrence occurred in two patients (upper lip and
cheek) 3 and 5 months postoperatively and was treated
with a sclerosant injection.
Discussion
Haemangiomas represent true tumours with rapidly
proliferating endothelial cells and capillary lumina. In
contrast, vascular malformations have a normal cell
turnover and dilated mature vascular structures that
persist throughout life [18].
About 50% of haemangiomas regress spontaneously with-
out after effects, which justifies not treating them;
progress in the other 50% of cases may be less
favourable [19]. Moreover, some haemangiomas not only
fail to involute but also progress further, inducing
deformities that may interfere with organ function [15].
In our series, 28 patients were subjected to surgical
Fig. 2
Child with the PHACES syndrome.
Table 1 Age distribution of the studied group




Table 2 The site of the lesion
Site No. (%)
Lip 8 (28.6)
Nasal tip 2 (7.1)
Occipital 1 (3.6)
Cheek 5 (17.8)




Angle of mandible 1 (3.6)
Glabella 1 (3.6)
Upper eye lid 1 (3.6)
Fig. 1
Extensive craniofacial haemangioma.
134 Annals of Pediatric Surgery 2011, Vol 7 No 4
Copyright © Annals of Pediatric Surgery. Unauthorized reproduction of this article is prohibited.
treatment because of complications (11 patients, 39.3%),
interference with vital functions (five patients, 17.8%),
haemangioma in areas prone to wear and tear (one
patient, 3.6%) and aesthetic surgery for patients causing
psychological troubles for the parents (11 cases, 39.3%).
As regards the aesthetic group, surgery was performed
during the last 8 months of the second year of life, which
is in contrast to patients presenting with complications,
most of whom were operated during the first year.
Iyer and Gough [19] stated that conservative treatment
for haemangioma is recommended, as resolution usually
occurs within first 6 years of life and surgery is reserved
for complications. In contrast, Van der Horst et al. [20]
concluded that after involution, only 6% of haemangiomas
had disappeared leaving normal skin. Also, Hoornweg
et al. [21], through their work on health-related quality of
life of haemagiomas for children and parents, believed
that having a haemangioma, especially if complicated or
in a visible location, could result in psychological pro-
blems later in life, mostly related to physical appearance,
which justifies early treatment. In agreement with this
and to alleviate the psychological stress caused by
haemangiomas for the family, 39.3% of our patients were
operated upon; we found that the parents were satisfied
with the postoperative cosmetic outcome.
Fig. 3
(a) Huge upper lip haemangioma. (b) Immediate postoperative view.
Fig. 4
(a) Ulcerating upper lip haemangioma. (b) Postoperative view (6 months after operation).
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Fig. 7
(a) Huge scalp haemangioma. (b) Immediate postoperative view.
Fig. 5
(a) Upper eye lid haemangioma. (b) Postoperative view (1 week after operation).
Fig. 6
(a) Glabellar haemangioma. (b) Immediate postoperative view.
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Long-term medical treatments for haemangiomas may
markedly affect body system functions, for example
steroid therapy, which may induce cushing syndrome,
delayed wound healing and immunosuppression [23].
IFNa is associated with spastic diplegia, neutropenia and
liver enzyme abnormalities. Propranolol causes bradycar-
dia, hypotension, bronchospasm and hypoglycaemia [24].
The side effects of bleomycin include painful swelling,
Fig. 8
(a) Ulcerating cheek haemangioma. (b) Immediate postoperative view.
Fig. 9
(a) Inflamed cheek haemangioma. (b) Postoperative view (3 months after operation).




Difficult suckling 3 (10.7)
Visual field obstruction 2 (7.1)
Inflammation and infection 4 (14.3)
Haemorrhage 2 (7.1)
Hyperdynamic circulation 1 (3.6)
Table 4 Postoperative complications
Complications Site No. (%)
Partial disruption Lip 2 (7.2)
Skin flap necrosis Cheek 1 (3.6)
Infection Scalp 1 (3.6)
Haematoma Retroauricular 1 (3.6)
Partial recurrence Cheek-upper lip 2 (7.2)
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ulceration, shock and pneumonic fibrosis [15]. Six
patients in our series were treated with oral prednisolone
for 4–6 weeks before surgery in another hospital. The
parents in this group observed an increase in weight and
appetite in their children, without an appreciable effect
on the haemangioma.
The questionable role of an intralesional injection of
haemangioma needs to be discussed. In the group studied,
five patients were injected with steroids, whereas three
patients were injected with a sclerosing agent. (Both groups
were injected elsewhere at the age of 6–14 months.) Three
patients of the first group showed complications of thinning
of the skin with underlying fat necrosis, whereas one
patient of the second group developed deep ulceration.
In accordance with McHeik et al. [18] and Watanabe
et al. [24], we found that an early surgical intervention
required for complications and haemangiomas affecting
vital functions yields good results especially in craniofa-
cial regions. Also, we found that the outcome after
excision of localized craniofacial haemangioma was
satisfactory, especially if causing psychosocial embarrass-
ment. The same observation was reported by Achauer
et al. [25] and Demiri et al. [26].
Despite the relatively high rate of complications in our
series (25%), we found that most of them were mild and
were treated conservatively, even for the two patients
who showed partial recurrence. The recurrence occurred
at the periphery of the scar 3 and 5 months after an
operation and was treated with a sclerosant injection.
In the present series, we found different degrees of
concern from most of the parents about the facies of their
children. In reality, this, together with the lack of com-
pliance on the part of the parents in terms of the lengthy
nonoperative treatment of haemangioma, were the factors
that led to the initiation of this work.
Conclusion
Surgical treatment is the prime goal in cases of haemangio-
ma affecting vital organs like the upper eye lid, nares or
areas close to the external auditory canal, haemangiomas in
areas prone to wear and tear before ulceration or
haemmorrhage like the lips, forehead and neap regions
and complicated haemangioma or haemangioma causing
psychological disturbances. Excisional surgery for craniofa-
cial haemangioma – when indicated – represents a short-
term therapy with good results in this early age group.
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